ES2017722B3 - Nuevo antibiotico glicopeptido. - Google Patents

Nuevo antibiotico glicopeptido.

Info

Publication number
ES2017722B3
ES2017722B3 ES87309017T ES87309017T ES2017722B3 ES 2017722 B3 ES2017722 B3 ES 2017722B3 ES 87309017 T ES87309017 T ES 87309017T ES 87309017 T ES87309017 T ES 87309017T ES 2017722 B3 ES2017722 B3 ES 2017722B3
Authority
ES
Spain
Prior art keywords
glycopeptide antibiotic
effective
antibiotic
new glycopeptide
swine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309017T
Other languages
English (en)
Inventor
Kelvin Scott Holdom
Hiroshi Maeda
John Cornish Ruddock
Junsuke Tone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Application granted granted Critical
Publication of ES2017722B3 publication Critical patent/ES2017722B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Feed For Specific Animals (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
ES87309017T 1986-10-16 1987-10-13 Nuevo antibiotico glicopeptido. Expired - Lifetime ES2017722B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624806A GB8624806D0 (en) 1986-10-16 1986-10-16 Glycopeptide antibiotic

Publications (1)

Publication Number Publication Date
ES2017722B3 true ES2017722B3 (es) 1991-03-01

Family

ID=10605842

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309017T Expired - Lifetime ES2017722B3 (es) 1986-10-16 1987-10-13 Nuevo antibiotico glicopeptido.

Country Status (12)

Country Link
US (2) US4992369A (es)
EP (1) EP0265143B1 (es)
JP (1) JPS63104998A (es)
AT (1) ATE56023T1 (es)
CA (1) CA1337759C (es)
DE (1) DE3764604D1 (es)
DK (1) DK167816B1 (es)
ES (1) ES2017722B3 (es)
GB (1) GB8624806D0 (es)
GR (1) GR3000885T3 (es)
IE (1) IE60376B1 (es)
PT (1) PT85921B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT90366A (pt) * 1988-04-28 1989-11-10 Beecham Group Plc Processo para a producao de compostos glicopeptidicos
DK0836619T3 (da) * 1995-07-05 2004-12-06 Aventis Bulk S P A Oprensning af dalbaheptid antibiotika ved hjælp af isoelektrisk fokusering

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923980A (en) * 1972-07-31 1975-12-02 Lilly Co Eli Antibiotic A-2315 and process for preparation thereof
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
GB1533677A (en) * 1976-06-29 1978-11-29 Lepetit Spa Antibiotic
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
ZA801629B (en) * 1979-04-07 1981-03-25 Lepetit Spa Antibiotic a/16686 and process for the preparation thereof
US4462942A (en) * 1982-07-30 1984-07-31 Eli Lilly And Company A47934 Antibiotic and process for production thereof
US4504467A (en) * 1983-10-21 1985-03-12 Eli Lilly And Company Glycopeptide derivatives
US4587218A (en) * 1983-10-21 1986-05-06 Eli Lilly And Company Novel bioconverting microorganisms
US4558036A (en) * 1984-02-17 1985-12-10 Eli Lilly And Company Actaplanin antibiotics

Also Published As

Publication number Publication date
JPH0432080B2 (es) 1992-05-28
CA1337759C (en) 1995-12-19
GR3000885T3 (en) 1991-11-15
DK538787A (da) 1988-04-17
IE872775L (en) 1988-04-16
PT85921B (pt) 1990-08-31
US4992369A (en) 1991-02-12
EP0265143B1 (en) 1990-08-29
JPS63104998A (ja) 1988-05-10
AU7978987A (en) 1988-04-21
DK167816B1 (da) 1993-12-20
ATE56023T1 (de) 1990-09-15
DE3764604D1 (de) 1990-10-04
EP0265143A3 (en) 1988-07-27
AU584525B2 (en) 1989-05-25
US4954482A (en) 1990-09-04
GB8624806D0 (en) 1986-11-19
IE60376B1 (en) 1994-07-13
EP0265143A2 (en) 1988-04-27
DK538787D0 (da) 1987-10-15
PT85921A (en) 1987-11-01

Similar Documents

Publication Publication Date Title
ATE166105T1 (de) Bacillus bakterium und dessen verwendung
ATE36860T1 (de) Polycyclische ether-antibiotika.
MY100945A (en) Polycyclic ether antibiotics
ES8308360A1 (es) Un procedimiento para la produccion de un nuevo antibiotico.
ATE47142T1 (de) Antibiotika, hergestellt durch kibdelosporangium- aridum-shearer-gen. nov., sp. nov. atcc 39323.
ATE89286T1 (de) Durch fermentation hergestellte antibiotika.
ES2017722B3 (es) Nuevo antibiotico glicopeptido.
AU552957B2 (en) Polycyclic ether antibiotic
AU2364988A (en) A method for inhibiting the growth of microorganisms